Researcher
Dmitri Krysko
- Keywords:cell death, cancer biology, innate immunity, DC vaccine, cancer immunity, cancer therapy, glioma, immunogenic cell death
- Disciplines:Cancer therapy, Cell death, Vaccinology, Cancer biology
Affiliations
- Department of Human Structure and Repair (Department)
Member
From1 Oct 2018 → Today - Department of Basic Medical Sciences (Department)
Member
From1 Oct 2016 → 30 Sep 2018 - Department of Biomedical molecular biology (Department)
Member
From1 Jan 2006 → 30 Sep 2016 - Department of Human Anatomy, Embryology, Histology and Medical Physics (Department)
Member
From1 Jan 2002 → 31 Dec 2005
Infrastructure
1 - 1 of 1
- Atomic Force Microscope (Consortium partner)
Projects
1 - 10 of 16
- IIMMUNO—FER—GUARD: Immunotherapy-based Modality Using Dendritic cells Loaded with FERroptotic cancer Lysates - Guarding against Glioblastoma and MelanomaFrom20 Dec 2023 → TodayFunding: IOF - technology concept exploration
- Generation of tumor neoantigens with photodynamic therapy: a new strategy for anticancer vaccines to fight head and neck cancerFrom1 Dec 2023 → TodayFunding: Horizon Europe - Marie Skłodowska-Curie-actions
- Capacity strengthening for development of pore-forming proteins obtained from a Cuban natural source as Immunogenic Cell Death Inducers for cancer immunotherapyFrom1 Sep 2023 → TodayFunding: VLIR-UOS South Initiatives
- Novel photosensitizers to push the limits of photodynamic cancer therapyFrom14 Aug 2023 → TodayFunding: IOF - technology concept exploration
- Triple punch against melanoma: photodynamic therapy, immunogenic cell death and photothermal ablationFrom1 Jan 2023 → TodayFunding: BOF - projects
- Mechanobiology control of immunogenic cell death by bio-polymers for cancer therapyFrom1 Oct 2022 → TodayFunding: BOF - projects
- Unravelling the role of immunogenic cell death and endothelial cells in the tumour microenvironment and immunityFrom1 Oct 2022 → TodayFunding: BOF - doctoral mandates
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imagingFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Harnessing tumor acidosis and immunogenic ferroptosis for an innovative treatment of peritoneal carcinomatosis with PUFA-loaded nanovesiclesFrom1 Jan 2022 → TodayFunding: FWO EOS
Publications
11 - 20 of 41
- Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation(2022)
Authors: Olga Krysko, Joshua H. Bourne, Elena Kondakova, Elena A. Galova, Katharine Whitworth, Maddy L. Newby, Claus Bachert, Harriet Hill, Max Crispin, Zania Stamataki, et al.
- Unraveling of functional activity of primary hippocampal neuron-glial networks in photodynamic therapy based on tetracyanotetra(aryl)porphyrazines(2022)
Authors: Maria O. Savyuk, Victoria D. Turubanova, Tatiana A. Mishchenko, Svetlana A. Lermontova, Larisa G. Klapshina, Dmitri Krysko, Maria V. Vedunova
- Ferroptosis and photodynamic therapy synergism : enhancing anticancer treatment(2021)
Authors: Tatiana A. Mishchenko, Irina V. Balalaeva, Maria V. Vedunova, Dmitri Krysko
Pages: 484 - 487 - Artificial intelligence predicts severity of COVID-19 based on correlation of exaggerated monocyte activation, excessive organ damage and hyperinflammatory syndrome : a prospective clinical study(2021)
Authors: Olga Krysko, Elena Kondakova, Olga Vershinina, Elena Galova, Anna Blagonravova, Ekaterina Gorshkova, Claus Bachert, Mikhail Ivanchenko, Dmitri Krysko, Maria Vedunova
- Cell death stage dictates the immunogenicity of ferroptotic cancer cells(2021)Volume: 206
Authors: Iuliia Efimova, Elena Catanzaro, Robin Demuynck, Louis Van der Meeren, Frauke Coppieters, Claus Bachert, Andre Skirtach, Olga Krysko, Dmitri Krysko
Number of pages: 1 - Analysis of immunogenic cell death in the tumor microenvironment of tumor spheroids(2021)Volume: 206
Authors: Robin Demuynck, Iuliia Efimova, Olga Krysko, Heidi Declercq, Dmitri Krysko
Number of pages: 1 - Immunogenic ferroptosis and where to find it?(2021)
Authors: Robin Demuynck, Iuliia Efimova, Faye Naessens, Dmitri Krysko
- Early but not late ferroptotic cancer cells are immunogenic in vitro and in vivo(2021)Volume: 11
Authors: Iuliia Efimova, Elena Catanzaro, Louis Van der Meeren, Claus Bachert, Andre Skirtach, Olga Krysko, Dmitri Krysko
Pages: 408 - 408 - Cyanoarylporphyrazines with high viscosity sensitivity : a step towards dosimetry-assisted photodynamic cancer treatment(2021)
Authors: Irina V. Balalaeva, Tatiana A. Mishchenko, Victoria D. Turubanova, Nina N. Peskova, Natalia Y. Shilyagina, Vladimir I. Plekhanov, Svetlana A. Lermontova, Larisa G. Klapshina, Maria V. Vedunova, Dmitri Krysko
- Targeting immunogenic cancer cell death by photodynamic therapy : past, present and future(2021)
Authors: Razan Alzeibak, Tatiana A. Mishchenko, Natalia Y. Shilyagina, Irina V. Balalaeva, Maria V. Vedunova, Dmitri Krysko